Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
lidamycin and benzoyl peroxide 1.2%/3.75% combination · 1 trial · 1 indication
Treatment Success defined as a score of 0 (clear) to 1 (almost clear) at day 99 (final study visit) by acne PGA scoring system. Full PGA scale from 0-5, with lower score indicating better drug efficacy
| Arm | Type | Description |
|---|---|---|
| lidamycin phosphate and benzoyl peroxide 1.2%/3.75% combo | EXPERIMENTAL | lidamycin phosphate and benzoyl peroxide 1.2%/3.75% combination gel; daily use for 99 days |
| Name | Type | Description |
|---|---|---|
| lidamycin phosphate and benzoyl peroxide 1.2%/3.75% combination | DRUG | At Day 15, patients will be re-assessed and dispensed the investigational product and instructed on its daily use. Patients will continue to return every 14 days to have their skin assessed until their final visit on day 99, one week after their 3rd menses on treatment (4th menses on study). |
Inclusion Criteria: * Women 18 years or older * Women who have had their first menses at least 12 months ago, and who currently have regular menses. * Subjects must be able to read and understand English, and be able and willing to complete the survey. * Subjects must have a self-reported complaint...